Extended Oral Antibiotics Increase Bacterial Resistance in Patients Who Fail 2-Stage Exchange for Periprosthetic

Mick P Kelly1, Jeremy M Gililland1, Brenna E Blackburn1

  • 1Department of Orthopaedic Surgery, University of Utah, Salt Lake City, UT.

Abstract

Insights

Prolonged oral antibiotics after periprosthetic joint infection (PJI) treatment may increase antibiotic resistance in subsequent infections. This study found a significantly higher rate of resistant organisms in patients who received oral antibiotics during reimplantation.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Microbiology

Background:

  • Recurrent periprosthetic joint infection (PJI) management often involves two-stage reimplantation.
  • Prolonged oral antibiotic administration is used to reduce recurrent PJI rates.
  • The impact of these antibiotics on subsequent bacterial resistance is not well understood.

Purpose of the Study:

  • To investigate whether prolonged oral antibiotics at second-stage reimplantation for PJI increase the rate of antibiotic resistance in subsequent infections.

Main Methods:

  • Retrospective review of patients undergoing two-stage exchange for chronic PJI (2014-2019).
  • Comparison of outcomes between patients receiving prolonged oral antibiotics at stage 2 reimplantation versus those who did not.
  • Primary outcome: presence of resistant organisms in subsequent infections; Secondary outcome: recurrent PJI rates. Multivariable analyses were performed.

Main Results:

  • Of 211 patients, 158 received prolonged oral antibiotics.
  • Recurrent PJI rates were similar: 15% with antibiotics vs. 21% without (P = .35).
  • PJI with resistant organisms was significantly higher in the antibiotic group (67% vs. 0%, P = .0001).

Conclusions:

  • Prolonged oral antibiotic use following two-stage exchange for PJI is associated with increased drug resistance in subsequent infections.
  • Further research is needed to optimize antimicrobial protocols considering the risks and benefits.
  • Antimicrobial stewardship is crucial in managing PJI to mitigate resistance development.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
65
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
293
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.0K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
11
Antibiotic Selection00:57

Antibiotic Selection

Overview
56.1K
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
65